Garden of Life Once Daily Women's Probiotic: Vaginal pH and Quality of Life Study
NCT ID: NCT05330091
Last Updated: 2022-08-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
200 participants
OBSERVATIONAL
2022-02-09
2022-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Single Group Study to Evaluate the Effects of a Probiotic Supplement on Vaginal Health.
NCT06506357
A Single Group Study to Evaluate the Effects of a Probiotic Vaginal Suppository on Vaginal Health.
NCT06565312
Effects of Oral Probiotic Product on Vaginal Microbial Community and Parameters of Vaginal Health
NCT03543982
A Study Assessing the Impact of a Women's Health Formulation on Vaginal Health and the Microbial Community
NCT07036666
Vaginal Detection of Orally Delivered Probiotic Strains in Healthy Women
NCT07246161
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Participants will receive ODWP at no charge for consumption over the course of the study. Participants will be instructed to start and continue consumption over three menstrual cycles (or equivalent timeframe) based on participant's menstrual status and her demonstrated ability to self-measure and report vaginal pH via the Validcare Study app based platform (aka "the app), which is provided as a free, downloadable 21 CFR Part 11 compliant interface for all patient facing activities and communication with/from the principal investigator for the study duration.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthy Women
Once Daily Women's Probiotic Placebo
Once Daily Women's Probiotic
Active product
Placebo
Placebo product
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Once Daily Women's Probiotic
Active product
Placebo
Placebo product
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Non-menopausal women must have a regular menstrual cycle (26-32 days)
3. Using birth control
4. Sexually active (intercourse at least 2x/month)
5. Agree to not introduce any other probiotic during the three months of study
Exclusion Criteria
2. No antibiotic treatment for at least 30 days
3. No active vaginal infection or symptoms of infection
4. No probiotic use for 30 days
5. Routine douching (except for immediately after menses)
19 Years
70 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Validcare, LLC
UNKNOWN
Garden of Life, LLC
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Robert Kaufmann, MD
Role: STUDY_DIRECTOR
Validcare, LLC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Syzygy Research Solutions
Wellington, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
VCODWP1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.